[1] |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识(2016) [J]. 中华皮肤科杂志, 2017,50(3):156⁃161. doi: 10.3760/cma.issn.0412⁃4030.2017.03.002.
|
[2] |
Asai Y, Tan J, Baibergenova A, et al. Canadian Clinical Practice Guidelines for rosacea[J]. J Cutan Med Surg, 2016,20(5):432⁃445. doi: 10.1177/1203475416650427.
|
[3] |
Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea[J]. J Eur Acad Dermatol Venereol, 2017,31(11):1775⁃1791. doi: 10.1111/jdv.14349.
|
[4] |
Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel[J]. Br J Dermatol, 2017,176(2):465⁃471. doi: 10.1111/bjd.15173.
|
[5] |
Piwnica D, Rosignoli C, de Ménonville ST, et al. Vasoconstriction and anti⁃inflammatory properties of the selective α⁃adrenergic receptor agonist brimonidine[J]. J Dermatol Sci, 2014,75(1):49⁃54. doi: 10.1016/j.jdermsci.2014.04.002.
|
[6] |
Moore A, Kempers S, Murakawa G, et al. Long⁃term safety and efficacy of once⁃daily topical brimonidine tartrate gel 0.5 for the treatment of moderate to severe facial erythema of rosacea: results of a 1⁃year open⁃label study[J]. J Drugs Dermatol, 2014,13(1):56⁃61.
|
[7] |
Hsu CC, Lee JY. Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonse⁃lective β⁃adrenergic blocker[J]. J Am Acad Dermatol, 2012,67(3):491⁃493. doi: 10.1016/j.jaad.2012.04.017.
|
[8] |
Arumanayagam M, Chan S, Tong S, et al. Antioxidant properties of carvedilol and metoprolol in heart failure: a double⁃blind randomized controlled trial[J]. J Cardiovasc Pharmacol, 2001,37(1):48⁃54.
|
[9] |
van Zuuren EJ, Kramer SF, Carter BR, et al. Effective and evidence⁃based management strategies for rosacea: summary of a Cochrane systematic review[J]. Br J Dermatol, 2011,165(4):760⁃781. doi: 10.1111/j.1365⁃2133.2011.10473.x.
|
[10] |
Kim MB, Kim GW, Park HJ, et al. Pimecrolimus 1 cream for the treatment of rosacea[J]. J Dermatol, 2011,38(12):1135⁃1139. doi: 10.1111/j.1346⁃8138.2011.01223.x.
|
[11] |
Garg G, Thami GP. Clinical efficacy of tacrolimus in rosacea[J]. J Eur Acad Dermatol Venereol, 2009,23(2):239⁃240. doi: 10.1111/j.1468⁃3083.2008.02822.x.
|
[12] |
Teraki Y, Hitomi K, Sato Y, et al. Tacrolimus⁃induced rosacea⁃like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application[J]. Dermatology, 2012,224(4):309⁃314. doi: 10.1159/000338693.
|
[13] |
El⁃Heis S, Buckley DA. Rosacea⁃like eruption due to topical pimecrolimus[J/OL]. Dermatol Online J, 2015,21(5). pii: 13030/qt7kd1048m.
|
[14] |
Patel NU, Shukla S, Zaki J, et al. Oxymetazoline hydrochloride cream for facial erythema associated with rosacea[J]. Expert Rev Clin Pharmacol, 2017,10(10):1049⁃1054. doi: 10.1080/17512433. 2017.1370370.
|
[15] |
Narayanan S, Hünerbein A, Getie M, et al. Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system[J]. J Pharm Pharmacol, 2007,59(8):1125⁃1130. doi: 10.1211/jpp.59.8.0010.
|
[16] |
Schulte BC, Wu W, Rosen T. Azelaic acid: evidence⁃based update on mechanism of action and clinical application[J]. J Drugs Dermatol, 2015,14(9):964⁃968.
|
[17] |
Schaller M, Gonser L, Belge K, et al. Dual anti⁃inflammatory and anti⁃parasitic action of topical ivermectin 1 in papulopustular rosacea[J]. J Eur Acad Dermatol Venereol, 2017,31(11):1907⁃1911. doi: 10.1111/jdv.14437.
|
[18] |
Leyden JJ. Randomized, phase 2, dose⁃ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel[J]. J Drugs Dermatol, 2014,13(6):685⁃688.
|
[19] |
Del RJQ, Schlessinger J, Werschler P. Comparison of anti⁃inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea[J]. J Drugs Dermatol, 2008,7(6):573⁃576.
|
[20] |
Schaller M, Schöfer H, Homey B, et al. State of the art: systemic rosacea management[J]. J Dtsch Dermatol Ges, 2016,14 Suppl 6:29⁃37. doi: 10.1111/ddg.13141.
|
[21] |
郝飞, 宋志强. 提高对玫瑰痤疮的认识水平[J]. 中华皮肤科杂志, 2017,50(3):153⁃155. doi: 10.3760/cma.j.issn.0412⁃4030.2017. 03.001.
|
[22] |
Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review[J]. Clin Ther, 2005,27(9):1329⁃1342. doi: 10. 1016/j.clinthera.2005.09.005.
|
[23] |
Noguera⁃Morel L, Gerlero P, Torrelo A, et al. Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases[J]. J Am Acad Dermatol, 2017,76(3):567⁃570. doi: 10.1016/j.jaad.2016.10.034.
|